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Membrane Topology of the Sodium Ion-dependent Citrate
Carrier of Klebsiella pneumoniae
EVIDENCE FOR A NEW STRUCTURAL CLASS OF SECONDARY TRANSPORTERS*
(Received for publication, July 3, 1996, and in revised form, July 23, 1996)
Marleen van Geest and Juke S. Lolkema‡
From the Department of Microbiology, Groningen Biotechnology and Biomolecular Sciences Institute,
University of Groningen, 9751NN Haren, The Netherlands
The predicted secondary structure model of the so-
dium ion-dependent citrate carrier of Klebsiella pneu-
moniae (CitS) presents the 12-transmembrane helix
motif observed for many secondary transporters. Bio-
chemical evidence presented in this paper is not con-
sistent with this model.
N-terminal and C-terminal fusions of CitS with the
biotin acceptor domain of the oxaloacetate decarboxyl-
ase of K. pneumoniae catalyze citrate transport, show-
ing the correct folding of the CitS part of the fusion
proteins in themembrane. Proteolysis experiments with
these fusion proteins revealed that the N terminus of
CitS is located in the cytoplasm, while the C terminus
faces the periplasm. The membrane topology was stud-
ied further by constructing a set of 20 different fusions
of N-terminal fragments of the citrate transporter with
the reporter enzyme alkaline phosphatase (CitS-PhoA
fusions). Most fusion points were selected in hydrophilic
areas flanking the putative transmembrane-spanning
domains in CitS that are predicted from the hydropathy
profile of the primary sequence. The alkaline phospha-
tase activities of cells expressing the CitS-PhoA fusions
suggest that the polypeptide traverses the membrane
nine times and that the C-terminal half of the protein is
characterized by two large hydrophobic periplasmic
loops and two large hydrophilic cytoplasmic loops.
CitS belongs to the family of the 2-hydroxycarboxylate
transporters in which also the citrate carriers, CitPs, of
lactic acid bacteria and the malate transporter, MleP, of
Lactococcus lactis are found. Since the hydrophobicity
profile of CitS is very similar to the hydrophobicity pro-
files of CitP and MleP, it is most likely that the new
structural motif of nine transmembrane segments is
shared within this new transporter family.
Bacterial secondary solute transporters use the free energy
stored in electrochemical gradients of H1 and/or Na1 to drive
the uptake of solutes by coupling the translocation of solute and
cation(s) across the membrane. In Klebsiella pneumoniae a
unique Na1-dependent citrate carrier (CitS) is induced upon
anaerobic growth on citrate (1). The gene coding for the trans-
porter has been cloned and sequenced (2, 3), and the enzyme
has been characterized and purified to homogeneity after ex-
pression in Escherichia coli. Studies with whole cells of E. coli
expressing CitS and with membrane vesicles prepared from
these cells have demonstrated that CitS obligatorily couples
the translocation of the divalent citrate anion (Hcit22) to the
translocation of two sodium ions and one proton (4, 5). More
recent studies with purified CitS (6) reconstituted in proteoli-
posomes have raised some doubt about the electrogenic nature
of the translocation catalyzed by the transporter, and it was
concluded that one of the two Na1 ions recycle during the
translocation of citrate (7).
The citS gene encodes a highly hydrophobic protein with a
predicted molecular mass of 47,531 Da. The gene is homologous
to the genes coding for the citrate carriers of lactic acid bacte-
ria, CitPs (8, 9), and the malate carrier of Lactococcus lactis,
MleP.1 The latter two transporters are not Na1-dependent but,
instead, translocate divalent citrate or malate in symport with
a single proton. CitP and MleP translocate negative charge into
the cell and are involved in secondary proton motive force
generation (11–13). The family of the three transporters is
termed the bacterial 2-hydroxycarboxylate transporters, since
the physiological substrates are citrate, malate, and lactate.
The global secondary structure of bacterial secondary solute
transporters is believed to be similar (e.g. see Ref. 14). The
proteins are predicted to consist of 12 transmembrane seg-
ments (TMSs),2 which traverse the membrane in an a-helical
structure. The helices are connected by hydrophilic loops that
are usually larger at the cytoplasmic side of the membrane
than at the periplasmic side. The models are predicted from the
hydropathy profile of the primary sequences in which the hy-
drophobic domains correspond to the TMSs. The orientation of
the protein in the membrane is determined by the “positive
inside rule” of von Heyne (15) and places both the N and C
termini in the cytoplasm. For a number of secondary transport-
ers like the lactose and melibiose transporters of E. coli, sub-
stantial evidence has been presented to support general fea-
tures of the models (Refs. 16 and 17; for a general review see
Ref. 18). Fig. 1 shows the secondary structure model for CitS
predicted from the primary structure. The protein also folds in
12 TMSs, but in contrast to what is observed for many other
secondary carriers, the C-terminal half is characterized by
large periplasmic and short cytoplasmic loops. Also, in this part
of the molecule, von Heynes “positive inside rule” is not very
apparent (19). The hydropathy profile of the primary sequences
is highly conserved in the 2-hydroxycarboxylate transporter
family, and similar models are predicted for CitP and MleP
(13).
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In this paper, we present biochemical evidence that is not
consistent with the predicted secondary structure of CitS. Tag-
ging of the N terminus and C terminus of CitS with the biotin
acceptor domain (BAD) of the oxaloacetate decarboxylase of K.
pneumoniae showed that the N and C termini are at the cyto-
plasmic and periplasmic face of the membrane, respectively,
indicating that the protein traverses the membrane an odd
number of times. Subsequent construction of fusion proteins
consisting of N-terminal fragments of CitS and the reporter
molecule alkaline phosphatase, PhoA (20), suggests that CitS
contains nine transmembrane-spanning segments.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
E. coli strains JM109, BL21(DE3), and CJ236 were routinely grown
in Luria broth medium at 37 °C. When appropriate, carbenicillin, chlor-
amphenicol, and kanamycin were added at final concentrations of 100,
50, and 20 mg/ml, respectively. CitS derivatives were expressed in E.
coli BL21(DE3) without induction with isopropyl 1-thio-b-D-galactopy-
ranoside. For in vivo biotinylation of CitS-BAD fusion proteins, D-biotin
was included in the medium at a final concentration of 1 mg/ml. Citrate
transport activity was detected as blue colonies on Simmons citrate
agar plates (Difco). Alkaline phosphatase activity was detected as blue
colonies on LB agar plates containing 5-bromo-4-chloro-3-indolyl-phos-
phate (toluidine salt; XP) at a concentration of 40 mg/ml.
Genetic Manipulations
Recombinant DNA Techniques—Standard recombinant DNA proce-
dures were used essentially as described by Sambrook et al. (21). The
citS gene was cloned downstream of the T7 promoter on a pBlueScript
phagemid (Stratagene) from which the Lac promoter region was deleted
(see below). All genetic manipulations of the citS gene were performed
in E. coli JM109, in which citS is not expressed. Expression of the genes
was obtained in E. coli BL21(DE3), which contains a chromosomal copy
of the gene coding for T7 polymerase (22). Site-directed mutants were
constructed following the Kunkel method (23). Nucleotide sequencing
was done using the dideoxy chain-terminating method (24) or with a
Vistra 725 automated sequencer.
Construction of NcoI Mutants pSNxxx—The Lac promoter region was
deleted from plasmid pBlueScript II SK by deletion mutagenesis. The
mutagenic primer was complementary to sequences downstream and
upstream of the promoter region. The nucleotide sequence of the primer
was 59-CAATTCCACACGCCTGGGGTGCC-39. Successful deletion of
the Lac promoter in the resulting vector pSKDL followed from blue/
white screening on 5-bromo-4-chloro-3-indoyl b-D-galactoside plates
and subsequent restriction analysis. A HindIII/BamHI fragment con-
taining the citS gene was restricted from pKScitS (5) and ligated into
pSKDL restricted with the same two enzymes. In the resulting plasmid,
pSKDLcitS, the citS gene was downstream of the T7 promoter on the
pBlueScript vector. Unique NcoI restriction sites (CCATGG) were in-
troduced throughout the citS gene in pSKDLcitS by site-directed mu-
tagenesis. The mutagenic oligonucleotides are listed in Table I. The
mutants were checked by restriction analysis and dideoxy sequencing of
the region around the NcoI site. The resulting plasmids are designated
pSNxxx in which xxx is the residue number of the methionine residue
in the CitS mutants coded by the ATG codon in the NcoI site. The
positions of the methionine residues are indicated by the arrows in Fig. 1.
Construction of BAD Fusion pSBxxx—Plasmid pTC57 containing the
coding sequence for the BAD of the oxaloacetate decarboxylase of K.
pneumoniae inserted in the lacY gene was a gift from H. R. Kaback and
described in Ref. 25. The BAD sequence was amplified by PCR using a
forward (59-GGGGGGCGGACCATGGCTGCTCCTGCTCC-39) and re-
verse (59-CGCCCCTGCCATGGCCCGACCCTCGATCAGGGTCATCA-
GGGTGTC-39) primer that introduced NcoI sites in the flanking re-
gions. The ATG codons of the NcoI sites were in frame with the BAD
sequence. The PCR fragment was digested by NcoI and ligated into the
NcoI sites of pSN1 and pSN445 (Fig. 2A) The orientation of the insert
was checked by restriction analysis using a unique NarI site that is
located asymmetrically in the BAD coding sequence. The resulting
plasmids, pSB1 and pSB445, code for the BAD fused to the N and C
termini of CitS, respectively.
Construction of PhoA Fusions pSAxxx—The HindIII/SacI fragment
of plasmid pPHO7 (26) containing an open reading frame coding for the
mature part of alkaline phosphatase was cloned into the multiple clon-
ing site of pSKDL. The unique NcoI site in the phoA gene was destroyed
by constructing a silent mutation by site-directed mutagenesis using
the following mutagenic primer 59-AACGTACCACGGCAATATC-39. An
NcoI site was engineered at the beginning of the open reading frame
with the primer 59-TGCAGGTCGACCATGGAGGATCCC-39. The re-
sulting plasmid is termed pSKphoA. The NcoI/SacI fragment of
pSKphoA, encoding mature PhoA, was ligated into plasmid pSNxxx
digested with NcoI and SacI (Fig. 2B). The resulting vectors encode
mature alkaline phosphatase fused to the C terminus of N-terminal
fragments of CitS of different lengths (CitS-PhoA fusions). The plas-
mids were designated pSAxxx, in which xxx indicates the fusion point.
The CitS-PhoA fusions indicated in Table I as SAxxx were con-
structed by the PCR technique. The coding region of the citS gene on
pSN1 was replaced by the phoA gene by ligating theNcoI/SacI fragment
of pSKphoA into pSN1 digested with the same two enzymes, yielding
pSKNphoA. Two N-terminal fragments of the citS gene, coding for
residues 1–46 and residues 1–103, were amplified by PCR while NcoI
sites were engineered around the start codon of citS and around resi-
dues 46 and 103, respectively. The obtained PCR products were ligated
in the NcoI site of pSKNphoA, yielding pSA46 and pSA103. Plasmids
pSA298, pSA319, pSA344, and pSA379 were constructed similarly by
amplifying the appropriate fragments of citS and ligating the fragments
in the NcoI site of mutant pSN174. All fusion sites and the inserted
PCR fragments were sequenced using the Vistra 725 automated
sequencer.
Biochemical Techniques
Alkaline Phosphatase Activity—Alkaline phosphatase activity of the
cells was assayed by measuring the rate of p-nitrophenyl phosphate
hydrolysis mainly as described by Michaelis et al. (27). After collection
of the cells, they were resuspended in 1 M Tris-HCl, pH 8, and after
incubation for 5 min at 37 °C the substrate p-nitrophenyl phosphate
was added at a final concentration of 0.66 mg/ml. Activities were ex-
pressed in Miller units (1000 3 A420/A600/time). The activities were
corrected for the background activity measured with E. coli BL21(DE3)
cells harboring plasmid pSKDLcitS, which amounted to 5 Miller units
for exponentially growing cells and 10 Miller units for overnight grown
cells.
Immunoblot Analysis—Cells were resuspended to an A600 of 10,
TABLE I
Oligonucleotides used for construction of NcoI sites in citS
and citS-phoA fusions






















a The numbers correspond to the residue that is coded by the ATG
codon in the NcoI site (underlined). Nucleotides in boldface type indi-
cate mutations. Constructs indicated as SNxxx represent NcoI site
mutants of citS constructed by site-directed mutagenesis. The oligonu-
cleotide is the mutagenic primer. Constructs indicated as SAxxx repre-
sent citS-phoA fusions constructed by PCR. The oligonucleotide is the
reverse primer, while the forward primer used was the mutagenic
primer used to construct SN1 or SN174 (see “Experimental Proce-
dures”).
b Periplasmic (Per), cytoplasmic (Cyt), or membrane (Mem) localiza-
tion of the methionine residue coded by the ATG codon according to the
predicted model in Fig. 1.
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diluted with one-third volume of loading buffer, and boiled for 3 min,
after which 2.5-ml samples were loaded onto SDS-polyacrylamide gels
containing 10 or 12.5% polyacrylamide. After running of the gels, the
proteins were transferred to Immobilon-P membranes (Millipore) by
semidry electrophoretic blotting. PhoA fusion proteins were detected
with monoclonal antibodies directed against PhoA at a dilution of
1:5000, and biotinylated proteins were detected with Ap-labeled
streptavidin also at a dilution of 1:5000. Antibodies and streptavidin
were visualized using the Western-lightTM chemiluminescence detec-
tion kit with CSPDTM as a substrate as recommended by the manufac-
turer (Tropix).
Preparation of Membranes and Spheroplasts—Cells were grown to
an A600 of 1, harvested, and washed once with 50 mM KPi, pH 7, 100 mM
NaCl. Inside-out (ISO) membrane vesicles were prepared by passing
the cell suspension through a French pressure cell operated at 20,000
p.s.i. Membranes were collected by ultracentrifugation for 45 min at
45,000 3 g in a Beckman Ti70 rotor. Right side-out (RSO) membrane
vesicles were prepared by the osmotic shock lysis procedure (28). The
membranes were stored in liquid nitrogen. Spheroplasts were prepared
essentially as described by Herzlinger et al. (29). Cells from a 150-ml
culture were resuspended in 7.5 ml of 10 mM Tris-HCl, pH 8, 0.75 M
sucrose, and incubated at 20 °C for 10 min. After the addition of 20 ml
of a 10 mg/ml lysozyme solution followed by additional incubation for
another 10 min, the suspension was diluted 3-fold with a solution
containing 1.5 mM K-EDTA and 10 mg/ml lysozyme. After incubation
for 1 h, the spheroplasts were harvested by centrifugation for 3 min in
a tabletop centrifuge (Eppendorf) and washed once in 100 mM potas-
sium phosphate, pH 7, 0.5 M sucrose.
Proteinase K Treatment—RSO and ISO membranes were resus-
pended to a protein concentration of 0.2 mg/ml in a total volume of 100
ml. Proteinase K was added in a volume of 10 ml containing 100 mg/ml.
The reaction was stopped by mixing an aliquot with a phenylmethyl-
sulfonyl fluoride solution at a final concentration of 1 mg/ml. The
experiment was performed on ice.
Transport Assays—Citrate uptake in whole cells was measured by
the rapid filtration method as described by Lolkema et al. (5). Uptake
was measured in 50 mM KPi, pH 6, containing 5 mM [1,5-
14C]citrate at
30 °C.
Materials—[1,5-14C]Citrate (110 mCi/mmol) was obtained from Am-
ersham International (Buckinghamshire, UK), Alkaline phosphatase-
labeled streptavidin from Boehringer Mannheim and the monoclonal
antibodies against alkaline phosphatase from Chemicon International,
Inc. (Temecula, CA). Oligonucleotides were obtained from EuroSe-
quence (Groningen, The Netherlands).
RESULTS
Construction of CitS Fusion Proteins—To determine the cel-
lular localization of the N and C termini of the Na1-dependent
citrate carrier of K. pneumoniae (CitS), gene fusions were con-
structed coding for the CitS protein fused with the BAD of the
a-subunit of the oxaloacetate decarboxylase of K. pneumoniae
at both the N and C termini and PhoA at the C terminus.
Expression and in vivo biotinylation of the fusion proteins was
analyzed by Western blotting of whole cell extracts using alka-
line phosphatase-labeled streptavidin, which binds specifically
to biotin, and a monoclonal antibody against alkaline phospha-
tase (Fig. 3). Detection with streptavidin resulted in a band
with a molecular mass of 22 kDa observed in all lanes (Fig. 3A).
This band corresponds to acetyl-CoA carboxylase of E. coli,
which is the only known biotinylated protein in E. coli. Cells
harboring plasmids pSB1 and pSB445 show an additional band
not observed in the control cells with an apparent mass of 48
kDa (Fig. 3A, lanes 2 and 3), demonstrating that the CitS-BAD
fusion proteins are synthesized, biotinylated in vivo, and fur-
FIG. 1. Hydropathy profile (top) and predicted secondary
structure model of CitS (bottom). A sliding window of 13 residues
was used in the calculation of the profile to emphasize the hydrophilic
regions. The secondary structure model was predicted from the hydrop-
athy profile using the algorithm of Eisenberg (10). The cylinders indi-
cate membrane-spanning segments. The lengths of the connecting loops
are roughly according to the number of residues in the loops. Arrows
indicate fusion sites in CitS-PhoA fusion proteins constructed by site-
directed mutagenesis (SNxxx) or PCR (SAxxx). FIG. 2. Construction of pSBxxx (A) and pSAxxx plasmids (B).
The genes are indicated by thick arrows. The NcoI site in pSNxxx may
be at any of the positions indicated by the arrows in Fig. 1. citS9 denotes
a 59 fragment of the citS gene.
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thermore stable. The size of the fusion proteins was the same
as observed before for a similar construct (6). The amount of
biotinylated SB1 (lane 3) is much higher than the amount of
biotinylated SB445 (lane 2). This is due to different levels of
expression of the two fusion proteins and/or to a less effective in
vivo biotinylation of SB445 (see below).
Growth of E. coli strain BL21(DE3) expressing wild type
CitS in rich medium does not result in expression of chromo-
somally encoded alkaline phosphatase (Fig. 3B, lane 1). With
cells expressing the CitS-PhoA fusion protein SA445 two major
bands are observed (lane 2). The band at an apparent mass of
83 kDa corresponds to the fusion protein, and the band at 49
kDa corresponds to mature PhoA, which indicates that a con-
siderable amount of the fusion protein is partially degraded.
The additional band at higher molecular mass corresponds to
the dimeric fusion protein.
Activity of the Fusion Proteins—Wild type E. coli cells exhibit
a negative phenotype on Simmons agar indicator plates be-
cause they lack a citrate uptake system. Expression of wild
type CitS results in citrate uptake and metabolism as evi-
denced by the appearance of blue colonies on the plates. Ex-
pression of the fusion proteins SB1, SB445, and SA445 all
result in a positive phenotype, indicative of active citrate trans-
port proteins. The citrate transport activity was examined in
more detail by uptake experiments using whole cells. The ini-
tial citrate uptake rate of cells expressing the different fusion
proteins was about half the rate observed with cells expressing
wild type CitS (Table II). Since the expression level of wild type
CitS is not known, specific activities cannot be given. The
citrate uptake activities of SB1 and SB445 are similar, suggest-
ing that the degree of biotin incorporation into the C-terminally
fused BAD is low rather than that the expression of the pro-
teins is very different. Although no solid conclusions can be
made about the specific activity of the fusion proteins, the data
show that the fusion proteins are active and, therefore, that the
correct folding of CitS in the membrane is maintained.
Localization of N and C Termini—The cellular localization of
the biotinylated N and C termini of SB1 and SB445 was studied
by determining the susceptibility of the BAD to proteinase K
digestion in ISO and RSO membrane vesicles. A complete loss
of the BAD-CitS fusion protein within 10 min was observed
when ISO membrane vesicles of cells expressing SB1 were
treated with proteinase K, indicating that the BAD is fully
accessible from the cytoplasmic side of the membrane (Fig. 4,
top). In contrast, treatment of RSO membrane vesicles pre-
pared from the same cells resulted in slow degradation of the
SB1 band at 48 kDa with a concomitant increase of a band at 31
kDa and a less intense band at 29 kDa. The former was stable
upon prolonged proteinase K treatment. In total, no loss of
signal intensity is observed, suggesting that the BAD itself is
not accessible but that the CitS part of the fusion protein is
cleaved in one or more periplasmic loops. These results show
that the N terminus of CitS is located at the cytoplasmic face of
the membrane. Surprisingly, the opposite result was obtained
with ISO and RSO membrane vesicles isolated from cells ex-
pressing the C-terminal CitS-BAD fusion SB445. Proteinase K
treatment of the RSO membranes resulted in complete and
rapid loss of the fusion protein (Fig. 4, bottom), whereas treat-
ment of the ISO membranes resulted in slower loss of the
48-kDa band and, at the same time, the appearance of two new
bands at lower molecular weights, presumably as a result of
cleavage of the CitS moiety in cytoplasmic loops. The total
intensity of the bands in the ISO membranes is reduced, which
may be caused by a different blotting efficiency of the
fragments.
The periplasmic location of the C terminus is consistent with
the alkaline phosphatase activity of the C-terminal PhoA fu-
sion SA445. Alkaline phosphatase is only enzymatically active
when it is translocated to the periplasm. The protein is syn-
thesized as an inactive precursor in the cytoplasm and targeted
FIG. 3. Western blot analysis of N- and C-terminal CitS fusion
proteins. Cells expressing CitS constructs were run on a 12.5% SDS-
polyacrylamide gel and, after blotting, analyzed for biotinylated pro-
teins (A) and alkaline phosphatase (B). A and B, lane 1, pSKDLcitS. A,
lane 2, pSB445; lane 3, pSB1. B, lane 2, pSA445. The arrows labeled SB,
SA, and PhoA indicate the CitS-BAD fusion protein, the CitS-PhoA
fusion protein and mature PhoA, respectively.
TABLE II
Activities of the CitS fusion proteins
Initial rates of citrate uptake were measured in whole cells express-
ing wild type CitS, CitS fused with its N terminus (SB1) and C terminus
(SB445) to the BAD of the oxaloacetate decarboxylase of K. pneumoniae,
and CitS fused with its C terminus to the mature form of alkaline
phosphatase (SA445).
Construct Citrate uptake activity Alkaline phosphatase activity





FIG. 4. Proteinase K digestion of SB1 and SB445. ISO and RSO
membrane vesicles were prepared from E. coli BL21(DE3) cells express-
ing SB1 (top) and SB445 (bottom). Membranes were treated for 0, 5, 10,
15, 30, and 45 min (lanes 1–6, respectively) with proteinase K. Samples
were loaded on a 10% (A) or 12.5% (B) SDS-polyacrylamide gel, and the
biotinylated proteins were detected with alkaline phosphatase-labeled
streptavidin. Top, lane M, biotinylated marker. Bottom, lane 7, as lane
6 except that proteinase K was omitted in the procedure. The positions
of the CitS-BAD fusion proteins and the resulting degradation products
(B) are indicated by arrows.
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to the periplasm by a signal sequence at the N terminus.
Membrane proteins or fragments thereof with the C terminus
in the periplasm can take over the function of the signal se-
quence, which is the basis of the frequently used phoA gene
fusion technique to determine the topology of membrane pro-
teins (20). The chromosomal copy of alkaline phosphatase is not
expressed when E. coli BL21(DE3) is grown in rich medium
(Fig. 3B, lane 1), and the cells appear as white colonies on
alkaline phosphatase indicator plates containing the chromo-
genic substrate XP. In contrast, E. coli cells harboring pSA445
grow as blue colonies on XP plates, and their alkaline phospha-
tase activity is 2 orders of magnitude higher than observed for
cells expressing wild type CitS (Table II). Together, these re-
sults show that the N terminus of CitS is located in the cyto-
plasm and that the C terminus is in the periplasm.
CitS-PhoA Fusion Proteins—The predicted secondary struc-
ture model (Fig. 1) of CitS derived from hydropathy profiling
showed 12 TMSs, suggesting that the N and C termini of CitS
are located at the same face of the membrane, which is at
variance with the experimental data presented above. Another
19 different positions in CitS were selected for the construction
of CitS-PhoA fusions. Most junctions were chosen in the hydro-
philic stretches of the protein flanking the predicted TMSs (Fig.
1, upward pointing arrows).
The alkaline phosphatase activity of E. coli BL21(DE3) cells
harboring the pSAxxx plasmids was determined by blue/white
screening on XP plates and by measuring the alkaline phos-
phatase activity of cells harvested in the early exponential
growth phase and in the stationary phase (Table III). The
alkaline phosphatase activities of exponentially growing cells
that grow as blue colonies on XP plates are at least 1 order of
magnitude higher than the activity of cells that grow as white
colonies. Cells with the latter phenotype showed virtually no
activity above background. In all cases the alkaline phospha-
tase activity increased when the same cells where grown over-
night and assayed again. Except for SA72 (white) and SA308
(blue) the difference between the blue and white phenotypes
was still 1 order of magnitude.
Cells expressing fusion proteins resulting in a blue pheno-
type on XP plates and harvested in the exponential growth
phase result in two major bands after Western blotting corre-
sponding to the fusion proteins and mature PhoA (Fig. 5, A and
B, odd numbered lanes). The relative mobilities of the upper
bands decrease according to the increasing size of the N-termi-
nal CitS fragments in the fusion proteins. Growth to the sta-
tionary phase results in the complete loss of the full-length
fusion proteins, together with a marked increase of mature
PhoA for the constructs shown in Fig. 5A (even numbered
lanes). Apparently, the fusion proteins are unstable under
these conditions, resulting in an accumulation of free PhoA in
the periplasm. This behavior was observed for all constructs
resulting in a blue phenotype, except for the two most N-
terminal fusion proteins, SA46 and SA103, and the C-terminal
fusion protein SA445, for which the full-length fusion protein
could still be detected in the stationary phase (Fig. 5B). The
general increase of the overall expression observed in the sta-
tionary phase is in line with the increased alkaline phospha-
tase activity (Table III). Cells expressing fusion proteins that
appear as white colonies on XP plates behave quite differently.
Representative examples are shown in Fig. 5C. The intensities
of the bands are much lower, but in all cases a full-length
fusion protein was observed with the cells from the exponential
cultures showing synthesis of the proteins. The bands corre-
sponding to mature PhoA were either absent or weak (lanes 1,
3, and 5). As observed with cells from the blue colonies, the
full-length fusion proteins disappeared when the cells were
grown to the stationary phase, but this was not accompanied by
a significant increase of free PhoA (lanes 2, 4, and 6). Appar-
ently, the PhoA part of the fusion protein is degraded rapidly
when it is released into the cytoplasm. The more N-terminal
fusions are present at higher intensities, but also more low
molecular weight degradation products are visible (Fig. 5D).
Full-length fusion protein SA72 is even present in the station-
ary growth phase together with a relatively high amount of
FIG. 5.Western blot analysis of the CitS-PhoA fusion proteins.
Cells expressing fusion proteins with a blue (A and B) and white (C and
D) phenotype on XP plates were run on a 12% SDS-polyacrylamide gel,
and the fusion proteins were detected with a monoclonal antibody
directed against PhoA. Cell samples were taken from exponentially
growing cultures (odd numbered lanes) and from overnight cultures
(even numbered lanes). A, SA174 (lanes 1 and 2), SA200 (lanes 3 and 4),
SA290 (lanes 5 and 6), SA308 (lanes 7 and 8), SA328 (lanes 9 and 10).
B, SA46 (lanes 1 and 2), SA103 (lanes 3 and 4), SA445 (lanes 5 and 6).
C, SA260 (lanes 1 and 2), SA389 (lanes 3 and 4), SA399 (lanes 5 and 6).
D, SA72 (lanes 1 and 2), SA141 (lanes 3 and 4). The arrow labeled PhoA
indicates mature PhoA. The band with the higher molecular weights
observed in the odd numbered lanes represents the full-length fusion
proteins.
TABLE III






Exponential Stationary PhoAfusions Predicted
SA46 Blue 375 770 Per Per
SA72 White 0 30 Cyt Cyt
SA103 Blue 66 126 Per Per
SA141 White 0 12 Cyt Cyt
SA174 Blue 400 650 Per Per
SA200 Blue 28 300 Per Cyt
SA239 White 0 15 Cyt Per
SA260 White 0 0 Cyt Per
SA290 Blue 85 295 Per Cyt
SA298 Blue 87 162 Per Mem
SA308 Blue 33 73 Per Per
SA319 Blue 86 583 Per Per
SA328 Blue 100 450 Per Per
SA344 Blue 72 176 Per Mem
SA360 Blue 103 211 Per Cyt
SA379 White 0 6 Cyt Mem
SA389 White 1 8 Cyt Per
SA399 White 0 8 Cyt Per
SA427 White 1 2 Cyt Per
SA445 Blue 171 680 Per Cyt
a Isolates were plated on LB agar plates containing the chromogenic
substrate XP for alkaline phosphatase (40 mg/ml).
b Alkaline phosphatase activity was measured of cells of exponential
growing cultures, after which the same cultures were allowed to grow
overnight and the activity was measured again.
c Periplasmic (Per), cytoplasmic (Cyt), or membrane (Mem) localiza-
tion determined from the PhoA activities and the predicted model in
Fig. 1.
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mature PhoA (lane 2), which may explain the somewhat higher
PhoA activity relative to the cells from the other white colonies.
The cellular localization of the free PhoA part of the fusion
proteins in cells with a blue and white phenotype is demon-
strated in Fig. 6 for two representative examples. Spheroplasts
were prepared from cells expressing fusion proteins SA174
(blue) and SA260 (white). Preparation of spheroplasts results
in the release of periplasmic proteins. Immunoblot analysis
showed that the spheroplasts of cells expressing SA174 had lost
almost all of the PhoA, while the full-length fusion protein was
present at the same intensity. In contrast, no difference in
intensities was observed between the cells and spheroplasts
with fusion SA260. Immunoblot analysis of cells from the ex-
ponential and stationary growth phases provides an independ-
ent assay of the cellular location of the PhoA moiety fused to
N-terminal fragments of CitS.
A New Membrane Topology Model—The activity of the CitS-
PhoA fusions proteins and the immunodetection analysis of the
expressed proteins results in the localization of the fusion
points as indicated in Table III. The cytoplasmic location of the
N terminus and the localization of the first five fusion points
(SA46, SA72, SA103, SA141, and SA174) conform to the model
in Fig. 1 that was predicted from the primary sequence. The
periplasmic localization of the two fusion sites flanking helix VI
(SA174 and SA200) indicates that the entire domain between
residues 174 and 200 is located in the periplasm and does not
span the membrane. As a consequence, the orientation of the
next TMSs in the membrane reverses, which is consistent with
the localization of fusion sites 239, 260, and 290 for predicted
TMSs VII and VIII. The seven active fusions at fusions points
290–360 indicate that this whole stretch is periplasmic and
that the prediction of TMSs IX and X is falsified by the CitS-
PhoA fusions. Fusions SA360 (blue) and SA379 (white) localize
predicted TMS XI but in the opposite orientation. Finally, the
cytoplasmic localization of fusion sites 389, 399, and 427 to-
gether with the periplasmic localization of the C terminus
shows that predicted TMS XII is outgoing. The new model for
the folding of CitS in the membrane based upon the results
presented in this study is depicted in Fig. 7.
DISCUSSION
CitS forms together with the CitPs and MleP the family of
the bacterial 2-hydroxycarboxylate transporters. The hydropa-
thy profiles of the primary sequence of the three transporters
are very similar, suggesting that their global structure is the
same (13).1 Secondary structure models predicted from the
hydropathy profiles show 12 TMSs (Fig. 1 for CitS), which
seems to be a general structural motif for bacterial secondary
transporters. For many membrane proteins, the predicted sec-
ondary structure is supported by biochemical evidence or even
crystallographic data. The data presented in this paper are not
consistent with the predicted model for CitS. The location of the
N and C termini was determined by proteolysis experiments
with CitS tagged at the N and C termini with a BAD, SB1 and
SB445, respectively. Fusion of the BAD to the two termini
leaves CitS active, indicating that the tags report on the native
structure of the transporter (Table II). The BAD in SB1 was
only accessible from the cytoplasmic side of the membrane,
while the BAD in SB445 was only accessible from the periplas-
mic side, demonstrating that the N and C termini of CitS are
located in the cytoplasm and periplasm, respectively (Fig. 4).
Subsequently, a number of CitS-PhoA fusions were constructed
to determine the number of times the polypeptide chain
traverses the membrane. In a first approach, the fusion sites
were selected in the hydrophilic regions flanking the predicted
TMSs (Fig. 1, lower arrows). Detailed studies with the lactose
permease, LacY, and the melibiose permease, MelB, of E. coli
have indicated that half of an outgoing TMS is enough to export
the PhoA part of a fusion protein to the periplasm and that half
of an ingoing TMS is enough to prevent export (17, 30, 31).
Therefore, the fusion sites in the hydrophilic stretches should
report the localization correctly as long as they are not part of
a TMS. Additional sites were selected especially in the C-
terminal half of the protein to make sure that the polypeptide
chain could not traverse the membrane in a helical conforma-
tion twice between two fusion points (Fig. 1, upper arrows). The
results of these studies are that CitS traverses the membrane
nine times with a cytoplasmic N terminus and a periplasmic C
terminus.
The observation that about half of an outgoing TMS of a
membrane protein is enough to export PhoA and that about
half of an ingoing TMS is enough to prevent export means that
the distance between two fusion points with the same high (or
low) PhoA activity that are separated by a membrane-crossing
segment may be as small as 25–30 residues (17). Therefore, two
sites at this distance with the same phenotype may be in one
continuous loop or halfway across the membrane in two adja-
cent TMSs. The latter would increase the number of times the
protein traverses the membrane by two. We have inspected this
possibility for the regions around the predicted TMSs that were
falsified by the PhoA studies. The distance between the sites in
SA174 and SA200 flanking predicted segment VI (Fig. 1) is 26
residues and both fusions have a blue phenotype. Positioning of
the two sites halfway across the membrane would predict
TMSs ranging approximately from residue 166 to 186 and from
residue 186 to 206. The mean hydrophobicity of the latter
stretch of residues is 0.07, which makes it highly unlikely that
FIG. 6. Cellular localization of free PhoA in cells with a white
and blue phenotype. Cells (lanes 1 and 3) expressing fusion proteins
SA174 (blue; lanes 1 and 2) and SA260 (white; lanes 3 and 4) and
spheroplasts derived from these cells (lanes 2 and 4) were analyzed for
alkaline phosphatase by Western blotting as described in the legend to
Fig. 5. The full-length fusion proteins and mature PhoA are indicated
by arrows.
FIG. 7. New secondary structure model of CitS. CitS-PhoA fu-
sions with high and low alkaline phosphatase activity are indicated by
filled and open circles, respectively.
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this is a TMS. Therefore, we conclude that sites 174 and 200
are part of one periplasmic loop. The high alkaline phosphatase
activity of the fusions at the hydrophilic sites 290, 328, and 360
that are separated by predicted TMSs IX and X (see Fig. 1)
prompted us to investigate this region in more detail. Fusions
were constructed at 10–15 residue spacings between positions
290 and 360. All of these constructs conferred high PhoA ac-
tivity and showed the behavior in the immunoblot analysis that
is typical for exported PhoA (Fig. 5). Fusion SA260 and the
additional fusions at positions 379 and 389 set the length of the
periplasmic loop to about 70 residues.
The low PhoA activity phenotype of cells expressing mature
PhoA fused to N-terminal fragments of a membrane protein at
cytoplasmic sites may be caused by low specific activity or by
low levels of expression of the fusion protein. In the first mech-
anism, PhoA accumulates in the cytoplasm in an inactive form
and can be detected by Western blotting (30). In the second
mechanism, cytoplasmic PhoA is unstable and rapidly de-
graded, and it is not, or is poorly, detected by Western blotting
(17, 31–33). Although both mechanisms are observed in differ-
ent studies, it is not clear why a particular mechanism occurs.
The CitS-PhoA fusions behave according to the second mecha-
nism. Cells expressing CitS-PhoA fusion proteins were ana-
lyzed in the exponential growth phase and in the stationary
phase, where proteolytic activity is usually higher. Full-length
fusion proteins are observed for most of the constructs in the
exponential growth phase, showing that the proteins are syn-
thesized (Fig. 5). However, the level of expression of the high
PhoA activity fusions is much higher than observed for the low
activity fusions, indicating rapid degradation of the latter.
Higher proteolytic activity in the stationary growth phase re-
sults in the degradation of the CitS fragment, and in the case of
the high activity fusions it results in the accumulation of PhoA
(Fig. 5A). The high PhoA activity observed in the stationary
phase indicates that this fraction is active (Table III). Further-
more, preparation of spheroplasts from cells expressing high
activity fusions results in the release of PhoA, showing its
periplasmic localization (Fig. 6). Apparently, active PhoA in the
periplasm is not very susceptible to proteolysis. In contrast, in
the case of low activity fusions, PhoA does not accumulate in
the stationary growth phase (Fig. 5C), and spheroplast prepa-
ration does not result in the release of the protein showing its
cytoplasmic localization. In conclusion, inactive PhoA in the
cytoplasm is more rapidly degraded than active PhoA in the
periplasm. Remarkably, full-length fusion proteins are still
observed in the stationary phase for the three most N-terminal
fusions (SA46, SA72, and SA103) and for the C-terminal fusion,
SA445 (Fig. 5, B and D). The higher stability of these fusion
proteins may be due to a higher stability of these particular
CitS fragments, which is the most reasonable explanation for
the C-terminal fusion in which CitS assumes its native confor-
mation (Table II).
The use of alkaline phosphatase as a periplasmic reporter
enzyme is advantageous, in principle, because a positive result,
i.e. a high activity fusion, requires the active export of the
mature reporter enzyme moiety into the periplasm. In contrast,
the use of b-galactosidase as a complementary cytoplasmic
reporter may give a positive phenotype as a result of many
artefacts (34). We have constructed 13 different CitS-LacZ fu-
sions at fusion sites that result in high and in low activity
CitS-PhoA fusions. Expression of the fusion proteins in differ-
ent strains of E. coli and under different levels of induction
never resulted in a significant difference in b-galactosidase
activity of cells. As a rule, the cells expressing the different
fusion proteins were either inactive or equally active in b-ga-
lactosidase activity. No further attempts were made to use the
CitS-LacZ fusions for the topological studies.
The BAD of the oxaloacetate decarboxylase of K. pneumoniae
was first used as a topological marker for membrane proteins
in a study of the lactose permease of E. coli (35). It was shown
that insertion of the BAD in periplasmic loops of LacY did not
result in translocation of the domain across the membrane.
Here we show that when BAD is fused to the C terminus of CitS
the domain is translocated and ends up in the periplasm. In
agreement with this observation, fusion of BAD to the C ter-
minus of excreted proteins results in export of the domain (36).
The periplasmic location of the BAD fused to the C terminus of
CitS may explain the low amount of biotin detected in the
Western blot analysis (Fig. 3). The similar citrate uptake ac-
tivities of the N- and C-terminal fusions suggest that the level
of expression of the fusion proteins is not very different. There-
fore, the difference must be in the degree of biotinylation of the
proteins. Biotinylation is a post-translational process that is
catalyzed by biotin ligase in the cytoplasm. The low incorpora-
tion in the C-terminal fusion may be due to competition be-
tween biotinylation and export to the periplasm of the BAD.
Recently, similar observations were made with the biotin ac-
ceptor domain of the transcarboxylase of Propionibacterium
shermanii fused to the inner membrane protein MalF (37).
The new topology model of CitS based on the data presented
in this paper represents a new structural class of secondary
transporters. The structural motif consists of nine transmem-
brane segments and two large extramembrane domains at each
side of the membrane in the C-terminal half of the protein (Fig.
7). The two cytoplasmic loops (residues 233–267 and 380–425)
are hydrophilic. The latter, most C-terminal loop is well con-
served in the 2-hydroxycarboxylate transporter family with 19
identical and 10 similar residues. The periplasmic loop be-
tween residues 170 and 210 is moderately hydrophobic and
contains a glycine-rich stretch of 18 residues that is the most
conserved region in the family. The second periplasmic domain
of 70 residues (290–360) is remarkable, since it consists of two
hydrophobic halves separated by a hydrophilic stretch of about
10 residues. Potentially, the hydrophobic regions of the two
periplasmic loops fold between the transmembrane segments
without completely crossing the membrane, as is believed to be
the case for the voltage-gated potassium channels, where such
structures are believed to form the translocation pore (38).
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